Authors' response to Hermann <i>et al</i>. Minimum quality criteria are needed in the assessment and communication of unexpected drug safety findings of marketed products from RCTs
- DOI
- 10.1111/j.1365-2125.2012.04180.x
- Published
- 2012-06-11
- Container
- British Journal of Clinical Pharmacology
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1111/j.1365-2125.2012.04180.x,
title = {Authors' response to Hermann <i>et al</i>. Minimum quality criteria are needed in the assessment and communication of unexpected drug safety findings of marketed products from RCTs},
author = {Koenraad Blot and Martin C. Michel},
year = {2012},
journal = {British Journal of Clinical Pharmacology},
doi = {10.1111/j.1365-2125.2012.04180.x},
url = {https://doi.org/10.1111/j.1365-2125.2012.04180.x}
}RIS
TY - JOUR TI - Authors' response to Hermann <i>et al</i>. Minimum quality criteria are needed in the assessment and communication of unexpected drug safety findings of marketed products from RCTs AU - Koenraad Blot AU - Martin C. Michel PY - 2012 JO - British Journal of Clinical Pharmacology DO - 10.1111/j.1365-2125.2012.04180.x UR - https://doi.org/10.1111/j.1365-2125.2012.04180.x ER -
APA
Blot, K., & Michel, M. C. (2012). Authors' response to Hermann <i>et al</i>. Minimum quality criteria are needed in the assessment and communication of unexpected drug safety findings of marketed products from RCTs. British Journal of Clinical Pharmacology. https://doi.org/10.1111/j.1365-2125.2012.04180.x
Source records
- crossref · retrieved 2026-09-27T08:38:51.181Z